Research in Action
A podcast by Oracle Corporation
Categories:
31 Episoade
-
AI's Role in Cancer Care Today and Tomorrow
Publicat: 20.08.2024 -
Transforming public health with unstructured data and NLP in FDA's Sentinel Initiative
Publicat: 23.07.2024 -
Empowering Patient-Centered Research Through Technology and Engagement
Publicat: 09.07.2024 -
Advancing clinical research through tech and teamwork
Publicat: 04.06.2024 -
How Innovation is Redefining Health and Life Sciences
Publicat: 22.05.2024 -
Exploring New Frontiers in Pharma: Mindsets, Data, AI, and Oracle
Publicat: 30.04.2024 -
Unlocking Innovation Through Public, Private, and Academic Partnerships
Publicat: 16.04.2024 -
Advancing scientific discovery with patient-led research
Publicat: 19.03.2024 -
Bringing clinical research into everyday patient care
Publicat: 05.03.2024 -
Building patient-friendly access to clinical trials
Publicat: 20.02.2024 -
Data hippies, real-world evidence, and precision medicine
Publicat: 06.02.2024 -
Advancing rare disease research with a patient-centered approach
Publicat: 24.01.2024 -
Automation, innovation, and the future of drug safety
Publicat: 09.01.2024 -
Patient empowerment, digital innovation, and rare diseases
Publicat: 05.10.2023 -
Biotech startup working with Oracle to innovate for pharma
Publicat: 20.09.2023 -
Science, Research, and Reaching the UN SDGs
Publicat: 06.09.2023 -
Talking AI, Computer Vision, Autism, and Small Data Problems
Publicat: 16.08.2023 -
Cloud technology’s impact on epidemiology research and public health
Publicat: 12.07.2023 -
Transforming healthcare research with technology's latest capabilities
Publicat: 28.06.2023 -
The rise of research entrepreneurs and why it matters
Publicat: 14.06.2023
"Research in Action" explores the dynamic world of life sciences, covering drug discovery, clinical trials, therapeutic development, and the pivotal role of real-world data and technology in connecting clinical research with patient care. Hear insightful conversations with scientists, clinicians, and leaders from pharma, biotech, and health.